RAINBOW stock news on Anadi Algo News

Monday, June 15, 2026
DISCLAIMER: AI-generated signals are for informational purposes only. All trading and investment decisions are solely the user's responsibility.|Past performance does not guarantee future results. Trade at your own risk.|Anadi Algo is not a SEBI-registered advisor. Consult a qualified financial advisor before acting on any recommendation.|DISCLAIMER: AI-generated signals are for informational purposes only. All trading and investment decisions are solely the user's responsibility.|Past performance does not guarantee future results. Trade at your own risk.|Anadi Algo is not a SEBI-registered advisor. Consult a qualified financial advisor before acting on any recommendation.|
Stock Landing|1 matching stories

RAINBOW Share Price, Latest News & Sentiment

Latest AI-analyzed news for RAINBOW, along with saved share-price context, sentiment, quarterly filing summary, and related names in one page.

Stock Coverage Hub

RAINBOW News Today

Emerging stock coverage

ICICI Prudential Mutual Fund has increased its stake in Rainbow Children's Medicare, signaling institutional confidence in the healthcare stock despite its recent price correction. This move by a prominent mutual fund could be seen as a positive indicator for the company and potentially the broader healthcare sector.

Coverage
1
recent stories
Sources
1
distinct publishers
Bias Split
1 bullish / 0 bearish
0 neutral stories
Window
1d
recent coverage span
Saved Quote Snapshot

RAINBOW

Last Updated
23 May 2026
Price
NA
NA
52W Range
NA - NA
exchange snapshot
PE / VWAP
PE NA
VWAP NA
Trend Read
bullish
Bullish stack · EMA 5 > 9 > 21 > 50
Business Context
Industry: NA
Sector Trail: NA
Listing Date: NA
Market Structure
F&O Eligible: No
Indices: NA
Snapshot Source: mcp+nse
Quarterly Read

Quarter ended 31 Dec 2024

Consolidated results
What This Quarter Says

This is the first public financial report for RAINBOW. The company reported sales of ₹398.08 crore and made a profit of ₹68.94 crore. These numbers show how much money the company earned and kept, which helps you understand its financial health.

Revenue
Rs 398.08 cr
up 4.3% vs previous filing
Profit
Rs 68.94 cr
up 2.9% vs previous filing
EPS / Finance Cost
EPS 6.76
Finance cost Rs 18.07 cr
Filing Context
Filed 10 Feb 2025, 6:46 pm
Figures are taken from the saved exchange filing, not from a live request.
Quick Reader Notes
  • Revenue this quarter: Rs 398.08 cr, up 4.3% vs previous filing.
  • Profit this quarter: Rs 68.94 cr, up 2.9% vs previous filing.
  • EPS gives a quick sense of per-share earnings: 6.76.
How To Read This

Treat this block as a saved quarter snapshot. First see whether revenue and profit are improving, then read the latest news below to judge whether recent headlines support that trend or work against it.

Related Stocks

Key People

Management and deal-maker mentions will appear here when they show up in recent stories.

RAINBOW FAQ

Why is RAINBOW in the news right now?

RAINBOW has appeared across 1 recent stories from 1 sources, which usually means there is a real flow of fresh headlines rather than a single isolated mention.

Is RAINBOW coverage bullish or bearish right now?

RAINBOW coverage is currently leaning bullish, with 1 bullish, 0 bearish, and 0 neutral analyzed stories in the recent window.

Which themes are moving with RAINBOW?

Recent RAINBOW coverage is clustering around Financial Services and Healthcare. Related names showing up alongside RAINBOW include ICICIPRULI.

How should I use this RAINBOW news page?

Use this page as a coverage hub for RAINBOW: start with the latest headlines, then check the dominant themes, related names, and saved market context before you form a trade or watchlist view.

Workflow View

Use RAINBOW coverage to build a cleaner watchlist.

A stock page is most useful when it helps you slow down, compare headlines, and separate one-off noise from a repeatable setup.

This is here if you want to go deeper, not as a push.Explore Anadi
Consider Rainbow Children's Medicare (RAINBOW) for potential upside given institutional buying interest after a significant correction.